http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021040196-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76d4ecbce1d513d2af22fd6c7eb62e94
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
filingDate 2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f28c9085ac3ce73835a672c82a7c7dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_562adabf0e85e8a08de31c5a5df61274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_655cab04a31af19ac0aee141fdc60b1f
publicationDate 2021-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021040196-A1
titleOfInvention Method of treating early stage dupuytren's disease
abstract The subject invention provides a method of treating an individual afflicted with early stage Dupuytren's disease characterized by the presence of one or more nodules on the individual's hand which comprises injecting into each nodule a pharmaceutical composition comprising an amount of an antihuman TNFa antibody or fragment thereof effective to treat the individual, wherein the pharmaceutical composition is in the form of a liquid and between 0.1 ml and 0.6 ml of the composition is injected into each nodule. This invention also provides for a pre-filled syringe for carrying out the above-described method.
priorityDate 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12444990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18631913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226551310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226551309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226524490

Total number of triples: 37.